Refsum Disease
Description
Refsum disease (RD) is a very rare, clinically variable, multisystemic metabolic disease, characterized by anosmia, early-onset retinitis pigmentosa and possible neurological manifestations, including neuropathy, and cerebellar ataxia, deafness, ichthyosis, skeletal abnormalities, and cardiac arrhythmia. It is characterized biochemically by accumulation of phytanic acid in plasma and tissues.
Clinical Features
Top most frequent phenotypes and symptoms related to Refsum Disease
- Ataxia
- Nystagmus
- Sensorineural hearing impairment
- Muscular hypotonia
- Cataract
- Ptosis
- Visual impairment
- Peripheral neuropathy
- Skeletal muscle atrophy
- Respiratory insufficiency
And another 28 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available REFSUM DISEASE have a estimated prevalence of 0.1 per 100k worldwide.— No data available about the known clinical features onset.
Alternative names
Refsum Disease Is also known as hmsn 4, phytanic-coa hydroxylase deficiency, heredopathia atactica polyneuritiformis, classic refsum disease, hereditary motor and sensory neuropathy type 4, adult refsum disease.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Refsum Disease Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
50 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...)
View the complete list with 129 more genes
Specificity
1 %
Genes
50 % |
![]() By Athena Diagnostics Inc (United States).
SHH, STIL, SIX3, TUBA8, SLC25A19, DEAF1, ARFGEF2, RAB3GAP1, CENPJ, NDE1, FKRP, ARX, ASPM, POMGNT1, POMT2, TUBA1A, COL4A1, CPT2, WDR62, DCX , (...)
View the complete list with 20 more genes
Specificity
3 %
Genes
50 % |
![]() By Athena Diagnostics Inc (United States).
SCN1A, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SHH, ST3GAL3, ST3GAL5, STIL, SIX3, SLC2A1, SLC35A2, SLC6A1, SLC6A8, SLC9A6, SMC1A, KDM5C, SMS , (...)
View the complete list with 214 more genes
Specificity
1 %
Genes
50 % |
![]() By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States).
AGPS, GNPAT, PEX7
Specificity
34 %
Genes
50 % |
![]() By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States).
PEX7, PHYH
Specificity
100 %
Genes
100 % |
![]() By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States).
SCP2, ACOX1, CAT, PEX26, DNM1L, AGPS, AGXT, GNPAT, AMACR, HSD17B4, TRIM37, PEX1, PEX10, PEX12, PEX13, PEX14, PEX16, PEX3, PEX6, PEX7 , (...)
View the complete list with 4 more genes
Specificity
9 %
Genes
100 % |
![]() By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
SLC25A13, SLC27A5, SMPD1, HNF1A, HNF1B, TJP2, UGT1A1, ABCG5, ABCG8, NPC2, INVS, CFTR, NPHP4, PEX26, TMEM216, CTRC, TRMU, DGUOK, DHCR7, CC2D2A , (...)
View the complete list with 24 more genes
Specificity
3 %
Genes
50 % |
You can get up to 131 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5 HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE; FPHH ACROKERATOSIS VERRUCIFORMIS; AKV HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39 MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE